Krzysztof Selmaj
University of Warmia and Mazury in Olsztyn(PL)
Publications by Year
Research Areas
Multiple Sclerosis Research Studies, Immunotherapy and Immune Responses, Peripheral Neuropathies and Disorders, Polyomavirus and related diseases, Rheumatoid Arthritis Research and Therapies
Most-Cited Works
- → A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis(2010)2,604 cited
- → Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis(2016)1,899 cited
- → Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis(2016)1,807 cited
- → Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis(2012)1,686 cited
- → Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro(1988)1,375 cited
- → Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial(2012)1,191 cited